Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial
Romrattaphan R., Dankulchai P., Prasartseree T., Sittiwong W., Thaweerat W., Junlabut S., Nitipitch S. Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial. Clinical Oncology Vol.53 (2026). doi:10.1016/j.clon.2026.104100 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116125
Title
Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial
